FOX RUN MANAGEMENT, L.L.C.

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1533457 GREENWICH, CT

Position in ARQT

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,001,027

-$65,786 QoQ

Shares Held

38,178

+3.9% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#18

of 62 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names. ARQT ranks #6 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NAMS	NewAmsterdam Pharma Co N.V.	59,477	$2,015,675
2	RPRX	Royalty Pharma plc	24,094	$1,350,950
3	IMVT	Immunovant, Inc.	34,827	$1,341,884
4	ASND	Ascendis Pharma A/S	4,726	$1,260,518
5	VKTX	Viking Therapeutics, Inc.	28,315	$1,104,568
6	ARQT	Arcutis Biotherapeutics, Inc. This page	38,178	$1,001,027
7	EXEL	Exelixis, Inc.	18,255	$993,254
8	EYPT	EyePoint, Inc.	58,528	$836,950

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,001,027	38,178	+3.9%	Shares	Sole	2026-08-04
2025-12-31	$1,066,813	36,736	+27.3%	Shares	Sole	2026-02-11
2025-09-30	$543,803	28,849	+156.0%	Shares	Sole	2025-11-12
2025-06-30	$157,963	11,267	-62.4%	Shares	Sole	2025-08-06
2025-03-31	$468,683	29,967	+76.8%	Shares	Sole	2025-05-13
2024-12-31	$236,057	16,946	-12.3%	Shares	Sole	2025-02-11
2024-09-30	$179,769	19,330	-33.0%	Shares	Sole	2024-11-12
2024-06-30	$268,202	28,839	+157.1%	Shares	Sole	2024-08-13
2023-09-30	$59,556	11,216	—	Shares	Sole	2023-11-07
No filing history on record for this holder in this stock.